Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation
Clin Infect Dis
.
2024 Mar 19:ciae152.
doi: 10.1093/cid/ciae152.
Online ahead of print.
Authors
Aniruddha Hazra
1
2
,
Connie Celum
3
,
Anne F Luetkemeyer
4
,
Jean-Michel Molina
5
,
Jeffrey D Klausner
6
Affiliations
1
Section of Infectious Diseases and Global Health, University of Chicago Medicine, Chicago, IL, USA.
2
Howard Brown Health, Chicago, IL, USA.
3
Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA, USA.
4
Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, CA, USA.
5
University of Paris Cité, Saint-Louis and Lariboisière Hospitals, Assistance Publique Hopitaux de Paris, France.
6
Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
PMID:
38501192
DOI:
10.1093/cid/ciae152
No abstract available